Our leadership team of experienced drug development professionals are responsible for day-to-day business operations, strategic development and oversight of over 100 drug development and operational staff at sites across the UK.
They lead teams with expertise spanning the full breadth of drug development including:
preclinical and medical sciences
regulatory affairs
project management
pharmacovigilance
clinical operations
data management
quality assurance
legal
These teams work to ensure all trials are conducted to international quality standards (ICH GCP) and all relevant regulations. Safety on our clinical studies is overseen by our in-house medical team and an external panel of experts on our Protocol Safety and Review Board.
We also work extensively with Cancer Research UK's broader research infrastructure and community, and have access to a large network of clinical oncologists who enable our clinical trials in the UK and Europe.
Contact us to find out more
Director of Drug Development
Lars leads the Centre for Drug Development
He oversees our early drug development portfolio of preclinical studies and first-in-human trials, working closely with academic and industry partners
Head of Medical Sciences
Sarah is a medical oncologist, who heads up our team of experienced oncology medics. Our medics support clinical trial design, protocol generation and provide on trial medical support. Sarah is also an Honorary Consultant in medical oncology at Barts and the London School of Medicine.
Chief Drug Development Scientist
Rob heads our preclinical and medical science teams. His teams support completion of the preclinical studies, advise on Biomarker strategy and outsourcing of Bioanalysis. They also lead the development of clinical trial protocols working with researchers in our Experimental Cancer Medicine Centres.
Head of Quality, Regulatory and Pharmacovigilance
Amber heads up our Quality Assurance, Regulatory Affairs, Pharmacovigilance and Medical Writing teams. They collectively ensure that all trials we sponsor are run to the highest quality and remain compliant with safety and regulatory standards.
Head of Study, Project and Portfolio Management
Raffaella leads a team of project leaders, clinical study managers and portfolio managers accountable for delivery of our drug development portfolio.
Head of Clinical Operations and Data Management
Steve leads our Clinical Operations and Data Management team, overseeing clinical trial databases and ensuring trials meet International Conference on Harmonisation GCP guidelines and UK regulations.
We're also supported by the expertise and independent peer review provided by the members of our New Agents Committee (NAC).
They review proposals arising from our Drug Development Project scheme and help select novel anti-cancer treatments to bring into early phase clinical trials.
Learn about the Drug Development Project scheme
Discover the latest news and press releases related to our work, including partnering, clinical trials and patient involvement activities.
We partner with academics, pharmaceutical and biotech companies worldwide to develop novel cancer treatments. Learn more about the opportunities to partner with us.
Join our team and help accelerate new cancer treatments for better patient outcomes.
